Related Experiment Video
Updated: May 27, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Nonruminant Nutrition Symposium: The role of glucagon-like peptide-2 in controlling intestinal function in human
1Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada T3B 6A8. sigalet@ucalgary.ca
Abstract:
The regulation of nutrient absorptive capacity is a critical factor in the normal growth and development of infants of all species. In human infants this is a common problem after surgical resection; the process of adaptation or upregulation of nutrient transport capacity is the physiologic process, which allows patients to transition to enteral feeding. The specific mechanisms that control this are still relatively poorly understood but are likely relevant for most mammals with an ontogeny of intestinal function related to the weaning process. Many actions of the entero-endocrine hormone glucagon-like peptide (GLP)-2 indicate that it may be a key factor in regulating physiologic intestinal development, nutrient absorptive capacity, and the process of adaptative upregulation of nutrient absorption after resection. This article will review the biology of GLP-2, which is preserved across a broad range of species. This will include the production of GLP-2 in the L cell, the regulation of GLP-2 release, and the mechanism of action. The GLP-2 receptor is specifically located on enteric neurons and pericryptal myofibroblast; thus, effects on the intestinal mucosa involve a second messenger. We will review the functioning of this system in the developing human infant and the role of GLP-2 in the regulation of adaptation, with the general implications for nutrient absorption in animals and humans.
More Related Videos
07:00Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine
Published on: February 26, 2019
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Regulation of Food Intake
Hormonal Regulation
Hypoglycemia and Glucagon
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...